danthron has been researched along with Obesity in 1 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, C | 1 |
| Wang, Z | 1 |
| Xia, R | 1 |
| Wei, L | 1 |
| Zhang, C | 1 |
| Zhang, J | 1 |
| Zhao, L | 1 |
| Wu, H | 1 |
| Kang, L | 1 |
| Yang, S | 1 |
1 other study available for danthron and Obesity
| Article | Year |
|---|---|
Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Animals; Anthraquinones; Anti-Obesity Agents; Diet, Hig | 2021 |